A
$ Value
$0
Shares
50,000
Price
$0
Filed
Nov 12
Insider
Name
Davis Matthew W.
Title
Chief Development Officer
CIK
0002094283
Roles
Officer
Transaction Details
Transaction Date
2025-11-10
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
50,000
Footnotes
The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. | The option will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.
Filing Info
Davis Matthew W.'s History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-09 | AQST | A | $0 |
| 2026-03-09 | AQST | A | $0 |
| 2025-11-10 | AQST | A | $0 |
| 2025-11-10 | AQST | A | $0 |
Other Insiders at AQST (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
TOTH A ERNEST JR
Chief Financial Officer
|
— | $243K | 2026-03-10 |
|
TOTH A ERNEST JR
SVP, Chief Financial Officer
|
— | — | 2025-03-07 |
|
Boyd Peter E.
Chief People Officer
|
— | $124K | 2026-03-10 |
|
Barber Daniel
President and CEO
|
— | $754K | 2026-03-10 |
|
BRAENDER LORI J
Chief Legal Officer
|
— | $167K | 2026-03-10 |
|
BRAENDER LORI J
Corporate Secretary
|
— | — | 2025-03-07 |
|
Jung Cassie
Chief Operating Officer
|
— | $191K | 2026-03-10 |
|
Korczynski Sherry
Chief Commercial Officer
|
— | $66K | 2026-03-10 |
|
Cioffi Melina
SVP, Regulatory Affairs
|
— | $106K | 2026-03-10 |
|
Davis Matthew W.
Chief Development Officer
|
— | — | 2026-03-09 |
|
Greenhawt Matthew J.
Chief Medical Officer
|
— | — | 2026-03-09 |